Date:11/12/2009

Adjust- GAAP GAAP ment Non-GAAP Non-GAAP RMB US$ RMB RMB US$ (unaudited)(unaudited) (unaudited) (unaudited)(unaudited) Net Revenues: EPIAO 150,549 22,055 -- 150,549 22,055 TPIAO 68,820 10,082 -- 68,820 10,082 Intefen 4,188 614 -- 4,188 614 Inleusin 1,166 171 -- 1,166 171 Iron 8,700 1,275 -- 8,700 1,275 Export 9,133 1,338 -- 9,133 1,338 Others 88 13 -- 88 13 Total net revenues 242,644 35,548 -- 242,644 35,548 Cost of revenues (18,990) (2,782) 365 (1) (18,625) (2,728) Gross profit 223,654 32,766 -- 224,019 32,820 Operating expenses Research and development costs (14,325) (2,099) 366 (1) (13,959) (2,045) Sales, marketing and distribution expenses (110,742) (16,223) 471 (1) (110,271) (16,154) General and administrative expenses (24,137) (3,536) 1,808 (1) (22,329) (3,271) Total operating expenses (149,204) (21,858) (146,559) (21,470) Operating income 74,450 10,908 77,460 11,350 Other income/ (expenses), net Interest income 9,163 1,342 -- 9,163 1,342 Grant income 281 41 -- 281 41 Disposal gain on available-for-sale securities 1,611 236 (1,611) (2) -- -- Impairment loss on
'/>"/>

SOURCE 3SBio Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Related biology technology :

1. 3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009
2. 3SBio Inc. to Hold 2009 Annual General Meeting on October 12, 2009
3. 3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor
4. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results
5. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
6. 3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009
7. 3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer
8. 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
9. 3SBio Inc. Announces Third Quarter 2008 Results
10. 3SBio Inc. Files for SFDA Approval of NuLeusin
11. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results